Insiders · Profile

MANHARD KIMBERLY

Director at Inhibrx Biosciences · EVP, Drug Development at HERON THERAPEUTICS, INC. /DE/. Filing since 1 Jun 2015. CIK 0001202094

Company
Date
Role
Action
Shares
Amount
Of holding
15 Sep 2026
Director
Sold at will
500
$52.53K
6.3%
14 Sep 2026
Director
Sold at will
500
$55.13K
5.9%
11 Sep 2026
Director
Sold at will
500
$55.89K
5.6%
9 Sep 2026
Director
Sold at will
500
$57.90K
5.3%
8 Sep 2026
Director
Sold at will
500
$57.57K
5.0%
28 Aug 2024
Director
Bought
10,000
$139.80K
opened
3 May 2022
EVP, Drug Development
Sold, plan not stated
1,504
$7.15K
12.2%
3 May 2021
EVP, Drug Development
Sold, plan not stated
1,529
$27.01K
48.3%
22 Dec 2020
EVP, Drug Development
Sold, plan not stated
10,000
$200.00K
100%
1 May 2020
Executive VP, Drug Development
Sold, plan not stated
1,158
$16.18K
100%
29 Nov 2019
Executive VP, Drug Development
Sold, plan not stated
24,000
$624.00K
100%
1 May 2019
Executive VP, Drug Development
Sold, plan not stated
1,109
$20.92K
100%
2 Nov 2018
Executive VP, Drug Development
Sold, plan not stated
494
$15.12K
100%
1 Oct 2018
Executive VP, Drug Development
Sold, plan not stated
6,000
$192.43K
100%
2 Jul 2018
Executive VP, Drug Development
Sold, plan not stated
6,000
$225.18K
100%
19 Mar 2018
Executive VP, Drug Development
Sold, plan not stated
18,000
$540.00K
100%
10 Jan 2018
Executive VP, Drug Development
Sold, plan not stated
7,584
$151.68K
100%
24 Apr 2017
Executive VP, Drug Development
Sold, plan not stated
21,542
$330.26K
100%
2 Jun 2015
Director
Sold, plan not stated
10,500
$247.59K
100%
1 Jun 2015
Director
Sold, plan not stated
2,708
$57.33K
100%
20 decisions on file.